Savara, Inc. (SVRA)
5.565
-0.02
(-0.45%)
USD |
NASDAQ |
Aug 24, 16:00
5.565
0.00 (0.00%)
After-Hours: 19:20
Savara Debt to Equity Ratio : 0.2117 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2117 |
| March 31, 2026 | 0.171 |
| December 31, 2025 | 0.1473 |
| September 30, 2025 | 0.316 |
| June 30, 2025 | 0.2469 |
| March 31, 2025 | 0.2005 |
| December 31, 2024 | 0.1564 |
| September 30, 2024 | 0.134 |
| June 30, 2024 | 0.2618 |
| March 31, 2024 | 0.218 |
| December 31, 2023 | 0.1905 |
| September 30, 2023 | 0.1803 |
| June 30, 2023 | 0.2996 |
| March 31, 2023 | 0.2668 |
| December 31, 2022 | 0.2431 |
| September 30, 2022 | 0.2239 |
| June 30, 2022 | 0.205 |
| March 31, 2022 | 0.19 |
| December 31, 2021 | 0.1793 |
| September 30, 2021 | 0.1655 |
| June 30, 2021 | 0.1541 |
| March 31, 2021 | 0.1449 |
| December 31, 2020 | 0.394 |
| September 30, 2020 | 0.3301 |
| June 30, 2020 | 0.3009 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2891 |
| December 31, 2019 | 0.2542 |
| September 30, 2019 | 0.2418 |
| June 30, 2019 | 0.2288 |
| March 31, 2019 | 0.2424 |
| December 31, 2018 | 0.227 |
| September 30, 2018 | 0.1309 |
| June 30, 2018 | 0.1852 |
| March 31, 2018 | 0.1622 |
| December 31, 2017 | 0.1285 |
| September 30, 2017 | 0.2041 |
| June 30, 2017 | 0.1955 |
| March 31, 2017 | 0.8051 |
| December 31, 2016 | 0.5596 |
| September 30, 2016 | 1.079 |
| June 30, 2016 | 0.9059 |
| March 31, 2016 | 0.7176 |
| December 31, 2015 | 0.6122 |
| September 30, 2015 | 0.4313 |
| June 30, 2015 | 0.0006 |
| March 31, 2015 | 0.0005 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Gilead Sciences, Inc. | 2.219 |
| Insmed, Inc. | 0.9865 |
| United Therapeutics Corp. | 0.00 |
| Vertex Pharmaceuticals, Inc. | 0.0977 |
| SELLAS Life Sciences Group, Inc. | 0.0054 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 192.14M |
| Total Liabilities (Quarterly) | 48.48M |
| Shareholders Equity (Quarterly) | 143.66M |
| Current Ratio | 10.13 |
| Net Debt Paydown Yield | -0.01% |